BCG
BCG (Tuberculosis)
Indications
Neonatal BCG in TB-endemic settings; Russia universal at 3–7 days; selective in much of EU.
Doses
- Dose 1: Single dose neonatal
Contraindications
- Symptomatic HIV infection (country-specific)
- Known or suspected immunodeficiency
- Generalized skin disease at injection site
Precautions
- Low birth weight / prematurity — national policies vary
Notes
- • Adverse events include regional BCGitis and disseminated BCG infection — see linked condition.
Adverse events
See clinical guidance for vaccine-related complications:
BCGitis / BCG complications